Results 111 to 120 of about 87,487 (309)
Background: Elderly men are at high risk of various prostatic diseases carrying high morbidity and mortality rates. For screening large populations, there is a need for a simple, reliable, and noninvasive test with high sensitivity and specificity ...
Monisha Choudhury, Savita Agarwal
doaj +1 more source
Pterostilbene is a potent anti-inflammatory and antioxidant used to treat benign prostatic hyperplasia, which is brought on by the induction of testosterone propionate.
Mohammed Ridha Jawad, Ghaith Ali Jasim
doaj +1 more source
Diabetes mellitus and prostatic hyperplasia. [PDF]
J B Bourke, J. P. Griffin
openalex +1 more source
Abstract Prostate cancer (PCa) is a multifaceted disease that envelops 1.41 million new cases globally. It is the second most common cancer reported in men. Its heterogeneity and indolent growth, coupled with incompetent early screening methods such as serum prostate‐specific antigen level estimations and digital rectal examinations, contribute to its ...
Anveshika Manoj+2 more
wiley +1 more source
Serum sex steroids, gonadotrophins and sex hormone-binding globulin in prostatic hyperplasia
Background: Benign prostatic hyperplasia (BPH) develops in elderly males when serum androgens are relatively lower than in healthy younger males, but it is not well understood whether and how sex steroids are altered in prostatic hyperplasia. It is also
Ansari Mohammad Abdul+2 more
doaj
The research progress on multi-omics analysis biomarkers of benign prostatic hyperplasia [PDF]
Benign prostatic hyperplasia (BPH) is one of the most common benign diseases among the ageing male population with increasing prevalence, which can cause lower urinary tract symptoms and seriously affect the quality of life of patients.
QIAN Xinhang+6 more
doaj +1 more source
The ABO blood groups of carcinoma of the oesophagus and of benign prostatic hyperplasia [PDF]
Will Beasley
openalex +1 more source
Senescent BPH epithelial cells secrete CXCL13 to recruit CD4+ T cells via CXCR5. Cytotoxic CD4+ T cells eliminate senescent cells through MHC‐II–dependent recognition. Tregs suppress, while B cells show minimal effect. This immune axis modulates senescent cell clearance and may influence BPH progression.
Zheng Li+16 more
wiley +1 more source
Basal cell proliferation in benign prostatic hyperplasia [PDF]
Gerald B. Dermer
openalex +1 more source